| SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures. The SPNE average annual return since 2015 is shown above.
The Average Annual Return on the SPNE average annual return since 2015 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SPNE average annual return since 2015 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SPNE average annual return calculation with any dividends reinvested as applicable (on ex-dates).